Events And
Presentations

Panel Discussion at 5th Global NASH Congress

May 27, 2022 at 9:35 AM BST

Panel Discussion: Clinical Endpoints for NASH Trials

Moderator: M. Scott Harris, M.D., Chief Medical Officer

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe